Company Synthetic Biologics Inc Nyse
Equities
US87164U1025
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 15-05-31 | |
Michael Kaleko
CTO | Chief Tech/Sci/R&D Officer | - | 12-02-29 |
- | - | ||
T. J. Swope
SEC | Corporate Secretary | - | - |
Manel Cascalló
PRN | Corporate Officer/Principal | - | 22-03-22 |
Vince Wacher
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Wolf
BRD | Director/Board Member | 60 | 05-12-31 |
John Monahan
BRD | Director/Board Member | 77 | 20-11-10 |
Jeffrey Kraws
CHM | Chairman | 59 | 05-12-31 |
Chief Executive Officer | 62 | 15-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,868,282 | 16,816,750 ( 94.12 %) | 720,233 ( 4.031 %) | 94.12 % |
Company contact information
Theriva Biologics, Inc.
9605 Medical Center Drive Suite 270
20850, Rockville
+301 417 4364
http://www.therivabio.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |